0,912  0,004  Respiratory analeptic
0,853  0,004  Analeptic
0,849  0,004  Antimycobacterial
0,821  0,004  Cardiovascular analeptic
0,752  0,004  UDP-glucuronosyltransferase substrate
0,750  0,022  Antiinflammatory
0,718  0,003  Carcinogenic, group 2B
0,706  0,002  Vasopressin 1A antagonist
0,701  0,002  Vasopressin 1 antagonist
0,681  0,005  Antineoplastic (carcinoma)
0,676  0,015  Antileukemic
0,637  0,003  Antiacne
0,642  0,031  Caspase 9 stimulant
0,639  0,029  Antineoplastic (breast cancer)
0,641  0,041  Apoptosis agonist
0,599  0,003  Antidiuretic hormone antagonist
0,609  0,017  Carcinogenic
0,601  0,010  Nitric oxide antagonist
0,577  0,005  Antineoplastic (squamous cell carcinoma)
0,584  0,024  Antineoplastic (colon cancer)
0,584  0,025  Antineoplastic (colorectal cancer)
0,549  0,016  Antineoplastic (pancreatic cancer)
0,526  0,014  Antiprotozoal (Leishmania)
0,517  0,016  Antineoplastic (glioma)
0,505  0,020  Antipsoriatic
0,510  0,038  Antibacterial
0,503  0,032  Antipruritic, allergic
0,473  0,018  Antineoplastic (glioblastoma multiforme)
0,483  0,030  Bone diseases treatment
0,455  0,005  Antiviral (Influenza A)
0,479  0,039  Immunosuppressant
0,442  0,007  Antiviral (Influenza)
0,473  0,049  Transcription factor NF kappa B inhibitor
0,453  0,031  FMO1 substrate
0,426  0,012  Abortion inducer
0,439  0,027  Sensitization
0,445  0,037  5 Hydroxytryptamine release stimulant
0,459  0,052  Antineoplastic (lung cancer)
0,409  0,013  Contraceptive
0,412  0,021  Antihypoxic
0,411  0,021  Calcium channel activator
0,441  0,068  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,387  0,029  Chemopreventive
0,426  0,069  TNF expression inhibitor
0,387  0,031  Mutagenic
0,379  0,027  Antineoplastic (liver cancer)
0,365  0,014  Antipruritic, non-allergic
0,390  0,040  Antiosteoporotic
0,368  0,019  UGT1A4 substrate
0,363  0,021  Antiparkinsonian, rigidity relieving
0,379  0,049  Antineoplastic (ovarian cancer)
0,343  0,015  Pneumotoxic
0,343  0,015  Antialcoholic
0,365  0,039  UGT2B4 substrate
0,326  0,005  Antispirochetal
0,354  0,041  Antineoplastic (multiple myeloma)
0,317  0,009  UGT2B9 substrate
0,351  0,043  NOS2 expression inhibitor
0,359  0,052  Apoptosis antagonist
0,343  0,036  Antineoplastic (endocrine cancer)
0,368  0,077  GABA C receptor rho-3 antagonist
0,309  0,018  Prostate disorders treatment
0,319  0,036  5 Hydroxytryptamine uptake stimulant
0,363  0,081  GST A substrate
0,307  0,025  UGT2B7 substrate
0,299  0,021  Lipocortins synthesis antagonist
0,294  0,021  Interferon gamma antagonist
0,288  0,019  UGT2B15 substrate
0,300  0,048  GST M1-1 substrate
0,254  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,320  0,071  AR expression inhibitor
0,285  0,038  Platelet adhesion inhibitor
0,251  0,008  Estrogen antagonist
0,249  0,007  Estrogen receptor beta antagonist
0,253  0,011  Antismoking
0,328  0,087  CYP3A4 substrate
0,288  0,055  Cytostatic
0,293  0,062  Renal disease treatment
0,311  0,082  ICAM1 expression inhibitor
0,243  0,015  UGT2B10 substrate
0,238  0,011  Antirickettsial
0,322  0,096  Ulceration
0,233  0,010  Contraceptive female
0,251  0,028  Hair growth stimulant
0,242  0,019  Antifungal enhancer
0,273  0,054  DNA synthesis inhibitor
0,269  0,053  Antiparasitic
0,251  0,038  Neurotrophic factor enhancer
0,219  0,007  Pregnane X receptor agonist
0,269  0,059  Hypolipemic
0,271  0,063  Proliferative diseases treatment
0,220  0,017  Arachidonic acid antagonist
0,278  0,078  FMO3 substrate
0,204  0,004  Hypercalcemia treatment
0,207  0,012  Antineoplastic alkaloid
0,207  0,015  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,242  0,051  VCAM1 expression inhibitor
0,327  0,136  5 Hydroxytryptamine release inhibitor
0,199  0,008  Postmenopausal disorders treatment
0,278  0,096  Prostate cancer treatment
0,263  0,084  CYP2C19 substrate
0,291  0,113  CYP2C9 substrate
0,237  0,059  RNA-directed DNA polymerase inhibitor
0,226  0,050  CYP2B6 inhibitor
0,191  0,018  Adenylate cyclase stimulant
0,192  0,022  Microtubule formation inhibitor
0,208  0,038  Skeletal muscle relaxant
0,249  0,080  Gastrin inhibitor
0,248  0,080  Interleukin agonist
0,202  0,036  Uterine stimulant
0,237  0,072  Antineoplastic (lymphoma)
0,174  0,009  Anabolic
0,253  0,090  Radioprotector
0,165  0,005  Oxytocin antagonist
0,174  0,014  Actinic keratosis treatment
0,189  0,035  Raynaud's phenomenon treatment
0,201  0,048  Succinate dehydrogenase inhibitor
0,233  0,081  Teratogen
0,164  0,012  Keratolytic
0,242  0,091  Chemoprotective
0,199  0,048  Acaricide
0,194  0,044  Protein kinase stimulant
0,214  0,063  UGT1A1 substrate
0,282  0,134  Histamine release inhibitor
0,243  0,095  Lipoprotein disorders treatment
0,226  0,078  Cardiodepressant
0,272  0,127  Cognition disorders treatment
0,203  0,057  Antiviral (Hepatitis)
0,157  0,012  UGT2B11 substrate
0,156  0,011  Tocolytic
0,207  0,064  Antihelmintic
0,235  0,092  Flavin-containing monooxygenase substrate
0,207  0,065  Non-steroidal antiinflammatory agent
0,145  0,004  Nicotinic alpha3beta2 receptor antagonist
0,181  0,040  Alpha-N-acetylglucosaminidase inhibitor
0,161  0,022  Ca2+-transporting ATPase inhibitor
0,153  0,014  Paget's disease treatment
0,147  0,013  Aromatase inhibitor
0,193  0,060  Muscle relaxant
0,150  0,020  Acetylcholine nicotinic antagonist
0,215  0,085  Embryotoxic
0,134  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,142  0,014  Ornithine decarboxylase inhibitor
0,137  0,011  Nicotinic alpha4beta2 receptor antagonist
0,214  0,088  Antihypotensive
0,145  0,020  GST T1-1 substrate
0,167  0,042  Skin irritative effect
0,148  0,023  Androgen antagonist
0,250  0,126  Antithrombotic
0,131  0,009  Narcotic antagonist
0,152  0,030  TRPA1 agonist
0,155  0,035  Ferrochelatase inhibitor
0,225  0,106  Transcription factor STAT3 inhibitor
0,122  0,005  Glutamate (mGluR6) antagonist
0,124  0,008  Uterine relaxant
0,173  0,057  Melanin inhibitor
0,205  0,090  UGT1A6 substrate
0,134  0,020  Antidote, mercury
0,124  0,010  Cannabinoid CB2 receptor antagonist
0,169  0,055  Antiparkinsonian, tremor relieving
0,115  0,004  Anesthetic inhalation
0,113  0,003  Parathyroid hormone antagonist
0,241  0,131  Cholesterol antagonist
0,114  0,005  Nicotinic receptor beta4 subunit antagonist
0,165  0,056  Genotoxic
0,216  0,109  Tyrosine 3 hydroxylase inhibitor
0,122  0,015  Na+ K+ transporting ATPase inhibitor
0,148  0,041  Vanilloid 1 agonist
0,191  0,085  Psychostimulant
0,208  0,102  Antipyretic
0,129  0,023  Tourette's syndrome treatment
0,170  0,065  Eye irritation, high
0,142  0,037  GABA C receptor agonist
0,140  0,036  GABA C receptor antagonist
0,226  0,123  NOS3 expression inhibitor
0,106  0,004  Vasopressin 1B antagonist
0,122  0,020  Antiprotozoal activity enhancer
0,104  0,003  Vitamin D receptor antagonist
0,168  0,067  Antiviral (Hepatitis C)
0,185  0,085  Cytotoxic
0,163  0,064  Carcinogenic, group 1
0,103  0,005  Postcoital contraceptive
0,117  0,020  Glycine receptor antagonist
0,149  0,054  Antiseptic
0,123  0,028  ABCA1 expression enhancer
0,104  0,011  Bombesin 3 receptor antagonist
0,119  0,026  Transcription factor NF kappa B stimulant
0,148  0,056  Carcinogenic, group 3
0,110  0,018  Hyperparathyroidism treatment
0,208  0,117  UGT1A9 substrate
0,164  0,073  UGT1A3 substrate
0,175  0,084  Hepatoprotectant
0,097  0,009  Nicotinic receptor alpha4 subunit antagonist
0,110  0,022  Estrogen receptor alpha antagonist
0,114  0,027  Inducible nitric-oxide synthase inhibitor
0,106  0,022  Neuronal nicotinic receptor antagonist
0,089  0,005  Adenylate cyclase 1 inhibitor
0,168  0,085  Diabetic nephropathy treatment
0,149  0,066  SULT1A3 substrate
0,130  0,048  SULT1A1 substrate
0,223  0,140  CTGF expression inhibitor
0,093  0,012  SULT2A1 substrate
0,233  0,152  Vasodilator, coronary
0,096  0,016  Androgen agonist
0,087  0,007  Vasopressin 2 antagonist
0,162  0,084  Phospholipase C inhibitor
0,110  0,031  Bile acid receptor antagonist
0,080  0,002  Progesterone receptor B antagonist
0,181  0,104  5 Hydroxytryptamine 3E antagonist
0,094  0,018  Acyl-CoA dehydrogenase inhibitor
0,102  0,027  Acetylcholine M4 receptor antagonist
0,169  0,095  Anesthetic general
0,131  0,057  Proteasome inhibitor
0,096  0,023  Glycine receptor agonist
0,195  0,123  Superoxide dismutase inhibitor
0,082  0,011  Estrogen receptor alpha agonist
0,121  0,052  Choleretic
0,080  0,012  5-Alpha-reductase inhibitor
0,092  0,025  Antidote, organophosphates
0,195  0,129  Antineoplastic (melanoma)
0,126  0,060  Cholesterol synthesis inhibitor
0,074  0,008  Retinoid X alpha receptor agonist
0,070  0,005  CXC chemokine 3 receptor antagonist
0,079  0,015  Heme oxygenase stimulant
0,109  0,047  Prolactin inhibitor
0,079  0,017  Nicotinic receptor alpha7 subunit antagonist
0,189  0,129  Spasmolytic
0,114  0,054  Antiviral (Poxvirus)
0,162  0,103  Sepsis treatment
0,176  0,119  Aldehyde oxidase inhibitor
0,110  0,053  Sulfotransferase substrate
0,130  0,073  Cocaine dependence treatment
0,126  0,068  Cholinergic antagonist
0,124  0,067  Acetylcholine antagonist
0,138  0,082  Antimutagenic
0,118  0,064  Protein-tyrosine phosphatase 1B inhibitor
0,197  0,143  Transcription factor STAT inhibitor
0,067  0,013  Progesterone antagonist
0,116  0,063  Antiviral (CMV)
0,113  0,062  Mucolytic
0,214  0,163  Ca(v)3.3 blocker
0,063  0,013  Retinoid X receptor agonist
0,112  0,062  Acetylcholine release stimulant
0,065  0,016  Aldosterone antagonist
0,175  0,126  Antineoplastic (non-small cell lung cancer)
0,088  0,040  Antibiotic
0,067  0,019  Pregnane X receptor antagonist
0,106  0,058  Adenylate kinase inhibitor
0,065  0,018  Potassium channel Kv1.3 blocker
0,205  0,159  Immunomodulator
0,214  0,169  Sodium/bile acid cotransporter inhibitor
0,049  0,005  CYP24 inhibitor
0,053  0,010  Retinoid X receptor antagonist
0,064  0,021  Purinergic P2X antagonist
0,139  0,097  Prostatic (benign) hyperplasia treatment
0,056  0,015  Liver X receptor alpha agonist
0,116  0,074  Antifungal (Pneumocystis)
0,099  0,058  Electrolyte absorption antagonist
0,107  0,066  Excitatory amino acid transporter EAAC1 inhibitor
0,087  0,047  Chymotrypsin inhibitor
0,132  0,093  Acetylcholine M1 receptor antagonist
0,051  0,011  Glutamate (mGluR8) agonist
0,068  0,029  Acetylcholine muscarinic agonist
0,138  0,099  CF transmembrane conductance regulator agonist
0,113  0,074  Antineoplastic antimetabolite
0,103  0,065  Expectorant
0,091  0,053  Carcinogenic, group 2A
0,044  0,007  Glutamate (mGluR3) agonist
0,134  0,097  GABA C receptor rho-2 antagonist
0,059  0,022  HCV NS3/NS4A protease inhibitor
0,039  0,004  NMDA receptor phencyclidine site antagonist
0,090  0,055  Acetylcholine agonist
0,064  0,029  Lipocortins synthesis agonist
0,085  0,051  Estrogen-related receptor beta agonist
0,067  0,033  Acetylcholine M5 receptor antagonist
0,044  0,010  Retinoid X alpha receptor antagonist
0,068  0,034  Antimycoplasmal
0,049  0,016  GABA uptake inhibitor
0,051  0,019  Guanylate cyclase inhibitor
0,039  0,007  Retinoid X gamma receptor agonist
0,147  0,115  LDLR expression enhancer
0,199  0,168  Antineoplastic (brain cancer)
0,042  0,012  Liver X receptor beta antagonist
0,047  0,018  Membrane dipeptidase inhibitor
0,113  0,084  Antiviral (Influenza B)
0,056  0,027  Dopamine transporter inhibitor
0,100  0,071  UGT2B1 substrate
0,053  0,024  Microtubule stabilization
0,073  0,045  Phosphofructokinase-1 inhibitor
0,089  0,062  Triose-phosphate isomerase inhibitor
0,047  0,020  Alpha 1L adrenoreceptor agonist
0,038  0,012  Nicotinic alpha3beta4 receptor agonist
0,051  0,025  Acetylcholine M1 receptor agonist
0,034  0,008  Retinoid X gamma receptor antagonist
0,075  0,050  Vanilloid 4 agonist
0,036  0,012  Liver X receptor alpha antagonist
0,030  0,006  Retinoic acid gamma receptor agonist
0,075  0,050  Glutamate dehydrogenase inhibitor
0,028  0,005  Retinoid X beta receptor antagonist
0,044  0,020  AMPA 4 receptor antagonist
0,054  0,030  Antiviral (Hepatitis D)
0,107  0,085  Shock treatment
0,094  0,071  Nitric-oxide synthase inhibitor
0,048  0,026  Nicotinic receptor alpha3 subunit antagonist
0,088  0,067  Glutamate release inhibitor
0,127  0,107  Antifungal (Cryptococcus)
0,135  0,114  Antipruritic
0,030  0,010  Vanilloid 2 agonist
0,029  0,009  Retinoid X beta receptor agonist
0,103  0,083  Photosensitizer
0,097  0,077  Antiprotozoal (Toxoplasma)
0,037  0,018  RNA-directed RNA polymerase stimulant
0,043  0,024  Kainate receptor agonist
0,055  0,036  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,052  0,034  Estrogen agonist
0,092  0,075  Glutathione S-transferase substrate
0,092  0,075  GABA C receptor rho-1 antagonist
0,022  0,005  Telomerase stimulant
0,024  0,009  Progesterone agonist
0,036  0,021  Tubulin agonist
0,102  0,088  Acetylcholine muscarinic antagonist
0,043  0,029  Heme oxygenase inhibitor
0,083  0,070  Sodium/hydrogen exchanger 5 inhibitor
0,107  0,094  Antiprotozoal (Amoeba)
0,029  0,016  Hedgehog signaling activator
0,020  0,007  Vitamin D receptor agonist
0,024  0,011  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,028  0,016  Nicotinic acid receptor 2 antagonist
0,084  0,072  HIV-1 integrase (Overall Integration) inhibitor
0,015  0,004  Progesterone receptor A antagonist
0,022  0,011  Retinoic acid beta receptor agonist
0,119  0,107  Farnesoid X receptor antagonist
0,032  0,022  ATP citrate lysase inhibitor
0,036  0,026  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,066  0,056  Anticholelithogenic
0,031  0,021  Liver X receptor antagonist
0,046  0,037  Glucose-6-phosphate isomerase inhibitor
0,104  0,096  Anesthetic
0,021  0,013  Retinoic acid alpha receptor antagonist
0,038  0,031  Dopamine D5 agonist
0,032  0,025  Carboxypeptidase B inhibitor
0,018  0,012  Methylmalonyl-CoA mutase inhibitor
0,020  0,013  5-Alpha-reductase 2 inhibitor
0,056  0,050  Ryanodine receptor antagonist
0,054  0,048  Biliverdin reductase inhibitor
0,047  0,041  Prolyl endopeptidase inhibitor
0,020  0,014  Antibiotic Quinolone-like
0,027  0,022  Purinergic P2Y15 antagonist
0,164  0,159  Antiprotozoal (Trypanosoma)
0,022  0,017  Retinoic acid receptor agonist
0,021  0,016  Estrone sulfatase inhibitor
0,036  0,031  Alpha 1d adrenoreceptor agonist
0,062  0,058  Glutamate (mGluR7) antagonist
0,005  0,002  Vitamin D-like
0,019  0,018  Corticosteroid-like
0,160  0,158  DNA damaging
0,027  0,026  Glucocorticoid antagonist
0,046  0,045  Aconitate hydratase inhibitor
0,040  0,039  Glutamate (mGluR group III) antagonist
0,027  0,026  Squalene synthetase inhibitor
0,052  0,051  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,025  0,025  Nicotinic alpha4beta2 receptor agonist
0,020  0,020  Prostaglandin F2 alpha agonist
0,061  0,061  Cannabinoid receptor antagonist
0,016  0,016  Retinoic acid receptor antagonist

